Home > Insider Trading > Filing (0001628280-23-019635)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
727207	Accelerate Diagnostics Inc	AXDX	Laboratory Analytical Instruments (3826)	841072256

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1938051	Michael Larry Mertz	C/O Accelerate Diagnostics, Inc. 3950 S. Country Club Road, Suite 470 Tucson AZ 85714	Chief Technology Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2023-05-22	10,000	$0.00	526,339	No	4	M	Direct
Common Stock	Disposition	2023-05-22	2,711	$0.72	523,628	No	4	S	Direct
Common Stock	Acquisiton	2023-05-22	2,836	$0.00	526,464	No	4	M	Direct
Common Stock	Disposition	2023-05-22	769	$0.72	525,695	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Restricted Stock Units	Disposition	2023-05-22	10,000	$0.00	10,000	$0.00
Common Stock	Employee Restricted Stock Units	Disposition	2023-05-22	2,836	$0.00	2,836	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
10,000			No	4	M	Direct
2,835			No	4	M	Direct

Footnotes

The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On May 20, 2021, the reporting person was granted a total of 30,000 restricted stock units, which vests in equal amounts every year over three years, which started vesting on May 20, 2022.
The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
The Reporting Person was granted RSUs, which represent a contingent right to receive one share of Common Stock for each RSU. On May 20, 2021, the reporting person was granted a total of 8,507 restricted stock units, which vests in equal amounts every year over three years, which started vesting on May 20, 2022.